These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38268072)

  • 1. Beyond bronchodilation: Illuminating the performance benefits of inhaled beta
    Hostrup M; Jessen S
    Scand J Med Sci Sports; 2024 Jan; 34(1):e14567. PubMed ID: 38268072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled beta
    Jeppesen JS; Jessen S; Thomassen M; Backer V; Bangsbo J; Hostrup M
    Scand J Med Sci Sports; 2024 Jan; 34(1):e14500. PubMed ID: 37880916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can β2-agonists have an ergogenic effect on strength, sprint or power performance? Systematic review and meta-analysis of RCTs.
    Riiser A; Stensrud T; Stang J; Andersen LB
    Br J Sports Med; 2020 Nov; 54(22):1351-1359. PubMed ID: 32747344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anabolic and lipolytic actions of beta
    Hostrup M; Jacobson GA; Jessen S; Lemminger AK
    Drug Test Anal; 2020 May; 12(5):597-609. PubMed ID: 31960603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ergogenic effects of inhaled beta2-agonists in non-asthmatic athletes.
    Wolfarth B; Wuestenfeld JC; Kindermann W
    Endocrinol Metab Clin North Am; 2010 Mar; 39(1):75-87, ix. PubMed ID: 20122451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined inhalation of beta2 -agonists improves swim ergometer sprint performance but not high-intensity swim performance.
    Kalsen A; Hostrup M; Bangsbo J; Backer V
    Scand J Med Sci Sports; 2014 Oct; 24(5):814-22. PubMed ID: 23834392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do inhaled beta(2)-agonists have an ergogenic potential in non-asthmatic competitive athletes?
    Kindermann W
    Sports Med; 2007; 37(2):95-102. PubMed ID: 17241101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled beta2 agonists and performance in competitive athletes.
    Kindermann W; Meyer T
    Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i43-7. PubMed ID: 16799103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terbutaline: level the playing field for inhaled β
    Jacobson GA; Hostrup M
    Br J Sports Med; 2017 Sep; 51(18):1323-1324. PubMed ID: 27461883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta2-Agonist Doping Control and Optical Isomer Challenges.
    Jacobson GA; Fawcett JP
    Sports Med; 2016 Dec; 46(12):1787-1795. PubMed ID: 27164986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of clenbuterol on athletic performance.
    Spann C; Winter ME
    Ann Pharmacother; 1995 Jan; 29(1):75-7. PubMed ID: 7711351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of exercise-induced asthma, respiratory and allergic disorders in sports and the relationship to doping: Part II of the report from the Joint Task Force of European Respiratory Society (ERS) and European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA(2)LEN.
    Carlsen KH; Anderson SD; Bjermer L; Bonini S; Brusasco V; Canonica W; Cummiskey J; Delgado L; Del Giacco SR; Drobnic F; Haahtela T; Larsson K; Palange P; Popov T; van Cauwenberge P; ; ;
    Allergy; 2008 May; 63(5):492-505. PubMed ID: 18394123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta2-Agonists at the Olympic Games.
    Fitch KD
    Clin Rev Allergy Immunol; 2006; 31(2-3):259-68. PubMed ID: 17085798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sports doping: emerging designer and therapeutic β2-agonists.
    Fragkaki AG; Georgakopoulos C; Sterk S; Nielen MW
    Clin Chim Acta; 2013 Oct; 425():242-58. PubMed ID: 23954776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. As-needed inhaled beta2-adrenoceptor agonists in moderate-to-severe asthma: current recommendations.
    Cockcroft DW
    Treat Respir Med; 2005; 4(3):169-74. PubMed ID: 15987233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nocturnal asthma uncontrolled by inhaled corticosteroids: theophylline or long-acting beta2 agonists?
    Holimon TD; Chafin CC; Self TH
    Drugs; 2001; 61(3):391-418. PubMed ID: 11293649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can asthma treatment in sports be doping? The effect of the rapid onset, long-acting inhaled beta2-agonist formoterol upon endurance performance in healthy well-trained athletes.
    Carlsen KH; Hem E; Stensrud T; Held T; Herland K; Mowinckel P
    Respir Med; 2001 Jul; 95(7):571-6. PubMed ID: 11453313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β₂-Agonists and physical performance: a systematic review and meta-analysis of randomized controlled trials.
    Pluim BM; de Hon O; Staal JB; Limpens J; Kuipers H; Overbeek SE; Zwinderman AH; Scholten RJ
    Sports Med; 2011 Jan; 41(1):39-57. PubMed ID: 21142283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
    Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle hypertrophic effect of inhaled beta
    Jessen S; Baasch-Skytte T; Onslev J; Eibye K; Backer V; Bangsbo J; Hostrup M
    J Physiol; 2022 May; 600(10):2345-2357. PubMed ID: 35218559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.